DK1027361T3 - Derivater af erythromycin med 6,11-bro - Google Patents

Derivater af erythromycin med 6,11-bro

Info

Publication number
DK1027361T3
DK1027361T3 DK98956314T DK98956314T DK1027361T3 DK 1027361 T3 DK1027361 T3 DK 1027361T3 DK 98956314 T DK98956314 T DK 98956314T DK 98956314 T DK98956314 T DK 98956314T DK 1027361 T3 DK1027361 T3 DK 1027361T3
Authority
DK
Denmark
Prior art keywords
erythromycin
bridge
derivatives
Prior art date
Application number
DK98956314T
Other languages
Danish (da)
English (en)
Inventor
Yat Sun Or
George Griesgraber
Daniel T Chu
Leping Li
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1027361T3 publication Critical patent/DK1027361T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK98956314T 1997-10-29 1998-10-29 Derivater af erythromycin med 6,11-bro DK1027361T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96040097A 1997-10-29 1997-10-29
US15826998A 1998-09-22 1998-09-22
PCT/US1998/022941 WO1999021864A1 (en) 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives

Publications (1)

Publication Number Publication Date
DK1027361T3 true DK1027361T3 (da) 2003-08-25

Family

ID=26854886

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98956314T DK1027361T3 (da) 1997-10-29 1998-10-29 Derivater af erythromycin med 6,11-bro

Country Status (23)

Country Link
EP (1) EP1027361B1 (de)
JP (1) JP2001521038A (de)
KR (1) KR20010031591A (de)
CN (1) CN1278266A (de)
AR (1) AR015986A1 (de)
AT (1) ATE239750T1 (de)
AU (1) AU1286799A (de)
BG (1) BG104425A (de)
BR (1) BR9813317A (de)
CA (1) CA2307828A1 (de)
CO (1) CO4990972A1 (de)
DE (1) DE69814441T2 (de)
DK (1) DK1027361T3 (de)
ES (1) ES2198766T3 (de)
HU (1) HUP0004323A2 (de)
IL (1) IL134996A0 (de)
NO (1) NO20002099L (de)
PL (1) PL340253A1 (de)
PT (1) PT1027361E (de)
SK (1) SK6342000A3 (de)
TR (1) TR200001140T2 (de)
TW (1) TW486485B (de)
WO (1) WO1999021864A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CN1589277A (zh) 2001-09-17 2005-03-02 奥索-麦克尼尔药品公司 6－o－氨基甲酸酯－11,12－内酯－酮内酯抗菌剂
CN1585775A (zh) 2001-12-05 2005-02-23 奥索-麦克尼尔药品公司 可用作抗菌药的红霉素的6－o－酰基酮内酯衍生物
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6753318B1 (en) * 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
WO2003095466A1 (en) * 2002-05-13 2003-11-20 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
US7273853B2 (en) 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6841664B2 (en) 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
EP1509538A1 (de) 2002-05-13 2005-03-02 Enanta Pharmaceuticals, Inc. 6,11 bizyklische erythromycinderivate
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
WO2005067564A2 (en) 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
US7265094B2 (en) 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
WO2005080408A1 (en) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7384922B2 (en) 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7589067B2 (en) 2005-10-12 2009-09-15 Enanta Pharmaceuticals, Inc. 6, 11-bridged tricyclic macrolides
US8273720B2 (en) 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US11673910B2 (en) 2017-04-28 2023-06-13 Zikani Therapeutics, Inc. Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0876388B1 (de) * 1995-11-08 2004-02-18 Abbott Laboratories Tricyclische erythromycinderivate

Also Published As

Publication number Publication date
TW486485B (en) 2002-05-11
ATE239750T1 (de) 2003-05-15
DE69814441T2 (de) 2004-04-08
PT1027361E (pt) 2003-09-30
CN1278266A (zh) 2000-12-27
DE69814441D1 (de) 2003-06-12
BG104425A (bg) 2001-01-31
CA2307828A1 (en) 1999-05-06
TR200001140T2 (tr) 2001-05-21
EP1027361B1 (de) 2003-05-07
IL134996A0 (en) 2001-05-20
HUP0004323A2 (hu) 2001-02-28
CO4990972A1 (es) 2000-12-26
EP1027361A1 (de) 2000-08-16
AU1286799A (en) 1999-05-17
KR20010031591A (ko) 2001-04-16
JP2001521038A (ja) 2001-11-06
SK6342000A3 (en) 2000-09-12
WO1999021864A1 (en) 1999-05-06
ES2198766T3 (es) 2004-02-01
PL340253A1 (en) 2001-01-29
BR9813317A (pt) 2000-08-22
AR015986A1 (es) 2001-05-30
NO20002099L (no) 2000-06-29
NO20002099D0 (no) 2000-04-25

Similar Documents

Publication Publication Date Title
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NL300150I1 (nl) 4"-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
DE59501802D1 (de) Substituierte 1H-3-Aryl-pyrrolidin-2,4-dion-Derivate
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
IS4970A (is) Setnar 6,6-heteró-bísýklískar afleiður
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
DK1027361T3 (da) Derivater af erythromycin med 6,11-bro
DE69718771T2 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
ATE246199T1 (de) 3-descladinose-2,3-anhydroerythromycin-derivate
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
ATE227282T1 (de) 2,4-diaminopyrimidin-derivate
ATE204279T1 (de) Diaza-spiro(3,5)nonan-derivate
NO20003825L (no) 1,3,4 - oxadiazolonderivater
DK1149106T3 (da) 4,5-azolo-oxindoler
PT1129079E (pt) Derivados de triazina 2,4-dissubstituidos
ID26368A (id) Turunan-turunan 2 deoksi higromisin
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
DK0810216T3 (da) Derivater af 10,11-dihydro-10-oxo-5H-dibenz/b/,f/azepin-5-carboxamid
DZ2644A1 (fr) Triazolo-Ä3,4-aÜ-pyridazine substituées en 1,2,4.